nodes	percent_of_prediction	percent_of_DWPC	metapath
Ziprasidone—HTR1A—stomach cancer	0.319	1	CbGaD
Ziprasidone—CYP3A7-CYP3A51P—Irinotecan—stomach cancer	0.0225	0.161	CbGbCtD
Ziprasidone—CYP3A7—Irinotecan—stomach cancer	0.0225	0.161	CbGbCtD
Ziprasidone—CYP3A5—Irinotecan—stomach cancer	0.0169	0.121	CbGbCtD
Ziprasidone—CYP3A7—Docetaxel—stomach cancer	0.0165	0.118	CbGbCtD
Ziprasidone—CYP3A7-CYP3A51P—Docetaxel—stomach cancer	0.0165	0.118	CbGbCtD
Ziprasidone—CYP3A5—Docetaxel—stomach cancer	0.0124	0.0884	CbGbCtD
Ziprasidone—CYP1A2—Fluorouracil—stomach cancer	0.0121	0.0862	CbGbCtD
Ziprasidone—HTR3A—myenteric nerve plexus—stomach cancer	0.0109	0.106	CbGeAlD
Ziprasidone—HTR3A—vagus nerve—stomach cancer	0.00728	0.0704	CbGeAlD
Ziprasidone—HTR7—myenteric nerve plexus—stomach cancer	0.00706	0.0683	CbGeAlD
Ziprasidone—CYP3A4—Irinotecan—stomach cancer	0.00659	0.047	CbGbCtD
Ziprasidone—CHRM3—muscle of abdomen—stomach cancer	0.00621	0.06	CbGeAlD
Ziprasidone—CYP2D6—Doxorubicin—stomach cancer	0.00567	0.0404	CbGbCtD
Ziprasidone—CYP3A4—Docetaxel—stomach cancer	0.00483	0.0345	CbGbCtD
Ziprasidone—HTR7—vagus nerve—stomach cancer	0.00471	0.0455	CbGeAlD
Ziprasidone—HTR7—vein—stomach cancer	0.00455	0.044	CbGeAlD
Ziprasidone—HTR2A—myenteric nerve plexus—stomach cancer	0.00441	0.0426	CbGeAlD
Ziprasidone—CYP3A4—Doxorubicin—stomach cancer	0.0036	0.0257	CbGbCtD
Ziprasidone—HTR2A—vagus nerve—stomach cancer	0.00294	0.0284	CbGeAlD
Ziprasidone—HTR2A—vein—stomach cancer	0.00284	0.0274	CbGeAlD
Ziprasidone—Lurasidone—HTR1A—stomach cancer	0.00228	0.406	CrCbGaD
Ziprasidone—HTR1B—blood vessel—stomach cancer	0.00187	0.0181	CbGeAlD
Ziprasidone—HTR1D—blood vessel—stomach cancer	0.00181	0.0175	CbGeAlD
Ziprasidone—DRD5—hematopoietic system—stomach cancer	0.00161	0.0156	CbGeAlD
Ziprasidone—HTR7—blood vessel—stomach cancer	0.00144	0.014	CbGeAlD
Ziprasidone—CHRM5—epithelium—stomach cancer	0.00132	0.0128	CbGeAlD
Ziprasidone—H1F0—hematopoietic system—stomach cancer	0.00125	0.0121	CbGeAlD
Ziprasidone—HTR3A—hematopoietic system—stomach cancer	0.00119	0.0115	CbGeAlD
Ziprasidone—DRD5—lymphoid tissue—stomach cancer	0.00113	0.011	CbGeAlD
Ziprasidone—H1F0—smooth muscle tissue—stomach cancer	0.0011	0.0106	CbGeAlD
Ziprasidone—H1F0—pancreas—stomach cancer	0.00102	0.00981	CbGeAlD
Ziprasidone—Clozapine—HRH4—stomach cancer	0.00101	0.18	CrCbGaD
Ziprasidone—CYP3A7—endocrine gland—stomach cancer	0.000966	0.00934	CbGeAlD
Ziprasidone—DRD5—endocrine gland—stomach cancer	0.000926	0.00895	CbGeAlD
Ziprasidone—SLC6A4—hematopoietic system—stomach cancer	0.000907	0.00876	CbGeAlD
Ziprasidone—HTR2A—blood vessel—stomach cancer	0.000901	0.00871	CbGeAlD
Ziprasidone—H1F0—lymphoid tissue—stomach cancer	0.000878	0.00848	CbGeAlD
Ziprasidone—CYP3A7—liver—stomach cancer	0.000871	0.00842	CbGeAlD
Ziprasidone—H1F0—digestive system—stomach cancer	0.000867	0.00838	CbGeAlD
Ziprasidone—HTR3A—digestive system—stomach cancer	0.000827	0.00799	CbGeAlD
Ziprasidone—HTR1A—hematopoietic system—stomach cancer	0.000805	0.00778	CbGeAlD
Ziprasidone—H1F0—bone marrow—stomach cancer	0.000799	0.00772	CbGeAlD
Ziprasidone—HTR7—hematopoietic system—stomach cancer	0.000769	0.00744	CbGeAlD
Ziprasidone—ADRA1A—hematopoietic system—stomach cancer	0.000742	0.00717	CbGeAlD
Ziprasidone—CYP3A7-CYP3A51P—liver—stomach cancer	0.000741	0.00716	CbGeAlD
Ziprasidone—KCNH2—hematopoietic system—stomach cancer	0.000717	0.00693	CbGeAlD
Ziprasidone—H1F0—endocrine gland—stomach cancer	0.000716	0.00692	CbGeAlD
Ziprasidone—CHRM3—smooth muscle tissue—stomach cancer	0.000712	0.00688	CbGeAlD
Ziprasidone—HTR7—epithelium—stomach cancer	0.000703	0.0068	CbGeAlD
Ziprasidone—ADRA1A—epithelium—stomach cancer	0.000678	0.00656	CbGeAlD
Ziprasidone—HTR7—smooth muscle tissue—stomach cancer	0.000678	0.00655	CbGeAlD
Ziprasidone—H1F0—liver—stomach cancer	0.000646	0.00624	CbGeAlD
Ziprasidone—SLC6A4—digestive system—stomach cancer	0.00063	0.00609	CbGeAlD
Ziprasidone—CYP1A2—hematopoietic system—stomach cancer	0.000614	0.00593	CbGeAlD
Ziprasidone—Aripiprazole—ADRB1—stomach cancer	0.000608	0.108	CrCbGaD
Ziprasidone—CYP3A5—hematopoietic system—stomach cancer	0.000592	0.00572	CbGeAlD
Ziprasidone—ADRA2C—pancreas—stomach cancer	0.000576	0.00557	CbGeAlD
Ziprasidone—HRH1—hematopoietic system—stomach cancer	0.000574	0.00555	CbGeAlD
Ziprasidone—HTR1B—endocrine gland—stomach cancer	0.000573	0.00554	CbGeAlD
Ziprasidone—CHRM2—endocrine gland—stomach cancer	0.00057	0.00551	CbGeAlD
Ziprasidone—ADRA2A—hematopoietic system—stomach cancer	0.000564	0.00545	CbGeAlD
Ziprasidone—CHRM3—digestive system—stomach cancer	0.000562	0.00543	CbGeAlD
Ziprasidone—Aripiprazole—HTR1A—stomach cancer	0.000544	0.0969	CrCbGaD
Ziprasidone—Trazodone—HTR1A—stomach cancer	0.000541	0.0964	CrCbGaD
Ziprasidone—HTR7—digestive system—stomach cancer	0.000535	0.00517	CbGeAlD
Ziprasidone—HRH1—epithelium—stomach cancer	0.000525	0.00507	CbGeAlD
Ziprasidone—ADRA1A—lymphoid tissue—stomach cancer	0.000522	0.00505	CbGeAlD
Ziprasidone—SLC6A4—endocrine gland—stomach cancer	0.000521	0.00504	CbGeAlD
Ziprasidone—CHRM1—endocrine gland—stomach cancer	0.000519	0.00502	CbGeAlD
Ziprasidone—HRH1—smooth muscle tissue—stomach cancer	0.000506	0.00489	CbGeAlD
Ziprasidone—H1F0—lymph node—stomach cancer	0.000495	0.00479	CbGeAlD
Ziprasidone—CYP3A5—pancreas—stomach cancer	0.000482	0.00466	CbGeAlD
Ziprasidone—HTR2A—hematopoietic system—stomach cancer	0.00048	0.00464	CbGeAlD
Ziprasidone—CHRM3—endocrine gland—stomach cancer	0.000464	0.00449	CbGeAlD
Ziprasidone—HTR1A—endocrine gland—stomach cancer	0.000463	0.00447	CbGeAlD
Ziprasidone—KCNH2—bone marrow—stomach cancer	0.000459	0.00444	CbGeAlD
Ziprasidone—ADRA2A—pancreas—stomach cancer	0.000459	0.00444	CbGeAlD
Ziprasidone—CYP3A4—hematopoietic system—stomach cancer	0.000444	0.00429	CbGeAlD
Ziprasidone—HTR7—endocrine gland—stomach cancer	0.000442	0.00427	CbGeAlD
Ziprasidone—HTR2A—epithelium—stomach cancer	0.000438	0.00424	CbGeAlD
Ziprasidone—CYP2D6—hematopoietic system—stomach cancer	0.000437	0.00422	CbGeAlD
Ziprasidone—CYP1A2—digestive system—stomach cancer	0.000427	0.00412	CbGeAlD
Ziprasidone—ADRA1A—endocrine gland—stomach cancer	0.000426	0.00412	CbGeAlD
Ziprasidone—HTR2A—smooth muscle tissue—stomach cancer	0.000423	0.00408	CbGeAlD
Ziprasidone—DRD2—endocrine gland—stomach cancer	0.000418	0.00404	CbGeAlD
Ziprasidone—KCNH2—endocrine gland—stomach cancer	0.000412	0.00398	CbGeAlD
Ziprasidone—CYP3A5—digestive system—stomach cancer	0.000412	0.00398	CbGeAlD
Ziprasidone—HRH1—digestive system—stomach cancer	0.000399	0.00386	CbGeAlD
Ziprasidone—HTR7—liver—stomach cancer	0.000399	0.00385	CbGeAlD
Ziprasidone—ADRA1A—liver—stomach cancer	0.000384	0.00372	CbGeAlD
Ziprasidone—ADRA2C—liver—stomach cancer	0.000366	0.00354	CbGeAlD
Ziprasidone—CYP1A2—endocrine gland—stomach cancer	0.000353	0.00341	CbGeAlD
Ziprasidone—CYP3A5—endocrine gland—stomach cancer	0.00034	0.00329	CbGeAlD
Ziprasidone—Clozapine—CYP2A6—stomach cancer	0.000336	0.0599	CrCbGaD
Ziprasidone—HTR2A—digestive system—stomach cancer	0.000334	0.00322	CbGeAlD
Ziprasidone—HRH1—endocrine gland—stomach cancer	0.00033	0.00319	CbGeAlD
Ziprasidone—ADRA2A—endocrine gland—stomach cancer	0.000324	0.00313	CbGeAlD
Ziprasidone—CYP1A2—liver—stomach cancer	0.000318	0.00307	CbGeAlD
Ziprasidone—CYP3A4—digestive system—stomach cancer	0.000309	0.00299	CbGeAlD
Ziprasidone—CYP3A5—liver—stomach cancer	0.000307	0.00296	CbGeAlD
Ziprasidone—CYP2D6—digestive system—stomach cancer	0.000304	0.00294	CbGeAlD
Ziprasidone—Clozapine—HTR1A—stomach cancer	0.000292	0.0521	CrCbGaD
Ziprasidone—KCNH2—lymph node—stomach cancer	0.000285	0.00275	CbGeAlD
Ziprasidone—ADRA2C—lymph node—stomach cancer	0.000281	0.00271	CbGeAlD
Ziprasidone—HTR2A—endocrine gland—stomach cancer	0.000276	0.00266	CbGeAlD
Ziprasidone—CYP3A4—endocrine gland—stomach cancer	0.000255	0.00247	CbGeAlD
Ziprasidone—CYP2D6—endocrine gland—stomach cancer	0.000251	0.00243	CbGeAlD
Ziprasidone—HTR2A—liver—stomach cancer	0.000249	0.0024	CbGeAlD
Ziprasidone—CYP3A4—liver—stomach cancer	0.00023	0.00222	CbGeAlD
Ziprasidone—HRH1—lymph node—stomach cancer	0.000228	0.00221	CbGeAlD
Ziprasidone—CYP2D6—liver—stomach cancer	0.000226	0.00219	CbGeAlD
Ziprasidone—ADRA2A—lymph node—stomach cancer	0.000224	0.00217	CbGeAlD
Ziprasidone—Angiopathy—Methotrexate—stomach cancer	0.000105	0.000414	CcSEcCtD
Ziprasidone—Vomiting—Irinotecan—stomach cancer	0.000105	0.000414	CcSEcCtD
Ziprasidone—Immune system disorder—Methotrexate—stomach cancer	0.000105	0.000412	CcSEcCtD
Ziprasidone—Dizziness—Fluorouracil—stomach cancer	0.000105	0.000412	CcSEcCtD
Ziprasidone—Visual impairment—Epirubicin—stomach cancer	0.000105	0.000412	CcSEcCtD
Ziprasidone—Mediastinal disorder—Methotrexate—stomach cancer	0.000105	0.000412	CcSEcCtD
Ziprasidone—Rash—Irinotecan—stomach cancer	0.000104	0.000411	CcSEcCtD
Ziprasidone—Dermatitis—Irinotecan—stomach cancer	0.000104	0.00041	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000104	0.00041	CcSEcCtD
Ziprasidone—Chills—Methotrexate—stomach cancer	0.000104	0.00041	CcSEcCtD
Ziprasidone—Headache—Irinotecan—stomach cancer	0.000104	0.000408	CcSEcCtD
Ziprasidone—Hypotension—Capecitabine—stomach cancer	0.000103	0.000407	CcSEcCtD
Ziprasidone—Insomnia—Docetaxel—stomach cancer	0.000103	0.000407	CcSEcCtD
Ziprasidone—Paraesthesia—Docetaxel—stomach cancer	0.000103	0.000404	CcSEcCtD
Ziprasidone—Alopecia—Methotrexate—stomach cancer	0.000103	0.000404	CcSEcCtD
Ziprasidone—Bradycardia—Doxorubicin—stomach cancer	0.000102	0.000403	CcSEcCtD
Ziprasidone—Dyspnoea—Docetaxel—stomach cancer	0.000102	0.000401	CcSEcCtD
Ziprasidone—Somnolence—Docetaxel—stomach cancer	0.000102	0.0004	CcSEcCtD
Ziprasidone—Mental disorder—Methotrexate—stomach cancer	0.000102	0.0004	CcSEcCtD
Ziprasidone—Eye disorder—Epirubicin—stomach cancer	0.000101	0.000399	CcSEcCtD
Ziprasidone—Tinnitus—Epirubicin—stomach cancer	0.000101	0.000398	CcSEcCtD
Ziprasidone—Malnutrition—Methotrexate—stomach cancer	0.000101	0.000398	CcSEcCtD
Ziprasidone—Erythema—Methotrexate—stomach cancer	0.000101	0.000398	CcSEcCtD
Ziprasidone—Haemoglobin—Doxorubicin—stomach cancer	0.000101	0.000397	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000101	0.000397	CcSEcCtD
Ziprasidone—Cardiac disorder—Epirubicin—stomach cancer	0.000101	0.000397	CcSEcCtD
Ziprasidone—Vomiting—Fluorouracil—stomach cancer	0.000101	0.000397	CcSEcCtD
Ziprasidone—Rhinitis—Doxorubicin—stomach cancer	0.000101	0.000396	CcSEcCtD
Ziprasidone—Dyspepsia—Docetaxel—stomach cancer	0.000101	0.000396	CcSEcCtD
Ziprasidone—Haemorrhage—Doxorubicin—stomach cancer	0.0001	0.000395	CcSEcCtD
Ziprasidone—Hepatitis—Doxorubicin—stomach cancer	0.0001	0.000395	CcSEcCtD
Ziprasidone—Insomnia—Capecitabine—stomach cancer	0.0001	0.000394	CcSEcCtD
Ziprasidone—Hypoaesthesia—Doxorubicin—stomach cancer	0.0001	0.000393	CcSEcCtD
Ziprasidone—Rash—Fluorouracil—stomach cancer	9.99e-05	0.000393	CcSEcCtD
Ziprasidone—Dermatitis—Fluorouracil—stomach cancer	9.98e-05	0.000393	CcSEcCtD
Ziprasidone—Pharyngitis—Doxorubicin—stomach cancer	9.97e-05	0.000392	CcSEcCtD
Ziprasidone—Paraesthesia—Capecitabine—stomach cancer	9.94e-05	0.000391	CcSEcCtD
Ziprasidone—Decreased appetite—Docetaxel—stomach cancer	9.94e-05	0.000391	CcSEcCtD
Ziprasidone—Headache—Fluorouracil—stomach cancer	9.93e-05	0.000391	CcSEcCtD
Ziprasidone—Urinary tract disorder—Doxorubicin—stomach cancer	9.92e-05	0.000391	CcSEcCtD
Ziprasidone—Oedema peripheral—Doxorubicin—stomach cancer	9.9e-05	0.00039	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Docetaxel—stomach cancer	9.88e-05	0.000389	CcSEcCtD
Ziprasidone—Connective tissue disorder—Doxorubicin—stomach cancer	9.87e-05	0.000389	CcSEcCtD
Ziprasidone—Dyspnoea—Capecitabine—stomach cancer	9.87e-05	0.000389	CcSEcCtD
Ziprasidone—Fatigue—Docetaxel—stomach cancer	9.86e-05	0.000388	CcSEcCtD
Ziprasidone—Angiopathy—Epirubicin—stomach cancer	9.85e-05	0.000388	CcSEcCtD
Ziprasidone—Urethral disorder—Doxorubicin—stomach cancer	9.85e-05	0.000388	CcSEcCtD
Ziprasidone—Nausea—Irinotecan—stomach cancer	9.83e-05	0.000387	CcSEcCtD
Ziprasidone—Immune system disorder—Epirubicin—stomach cancer	9.81e-05	0.000386	CcSEcCtD
Ziprasidone—Mediastinal disorder—Epirubicin—stomach cancer	9.79e-05	0.000385	CcSEcCtD
Ziprasidone—Constipation—Docetaxel—stomach cancer	9.78e-05	0.000385	CcSEcCtD
Ziprasidone—Back pain—Methotrexate—stomach cancer	9.77e-05	0.000385	CcSEcCtD
Ziprasidone—Dyspepsia—Capecitabine—stomach cancer	9.75e-05	0.000384	CcSEcCtD
Ziprasidone—Chills—Epirubicin—stomach cancer	9.74e-05	0.000383	CcSEcCtD
Ziprasidone—Arrhythmia—Epirubicin—stomach cancer	9.7e-05	0.000382	CcSEcCtD
Ziprasidone—Visual impairment—Doxorubicin—stomach cancer	9.68e-05	0.000381	CcSEcCtD
Ziprasidone—Decreased appetite—Capecitabine—stomach cancer	9.63e-05	0.000379	CcSEcCtD
Ziprasidone—Alopecia—Epirubicin—stomach cancer	9.6e-05	0.000378	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Capecitabine—stomach cancer	9.56e-05	0.000376	CcSEcCtD
Ziprasidone—Fatigue—Capecitabine—stomach cancer	9.55e-05	0.000376	CcSEcCtD
Ziprasidone—Vision blurred—Methotrexate—stomach cancer	9.52e-05	0.000375	CcSEcCtD
Ziprasidone—Mental disorder—Epirubicin—stomach cancer	9.51e-05	0.000374	CcSEcCtD
Ziprasidone—Constipation—Capecitabine—stomach cancer	9.47e-05	0.000373	CcSEcCtD
Ziprasidone—Erythema—Epirubicin—stomach cancer	9.45e-05	0.000372	CcSEcCtD
Ziprasidone—Malnutrition—Epirubicin—stomach cancer	9.45e-05	0.000372	CcSEcCtD
Ziprasidone—Feeling abnormal—Docetaxel—stomach cancer	9.43e-05	0.000371	CcSEcCtD
Ziprasidone—Nausea—Fluorouracil—stomach cancer	9.41e-05	0.00037	CcSEcCtD
Ziprasidone—Eye disorder—Doxorubicin—stomach cancer	9.39e-05	0.00037	CcSEcCtD
Ziprasidone—Tinnitus—Doxorubicin—stomach cancer	9.37e-05	0.000369	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Docetaxel—stomach cancer	9.35e-05	0.000368	CcSEcCtD
Ziprasidone—Anaemia—Methotrexate—stomach cancer	9.34e-05	0.000367	CcSEcCtD
Ziprasidone—Cardiac disorder—Doxorubicin—stomach cancer	9.33e-05	0.000367	CcSEcCtD
Ziprasidone—Flatulence—Epirubicin—stomach cancer	9.32e-05	0.000367	CcSEcCtD
Ziprasidone—Back pain—Epirubicin—stomach cancer	9.14e-05	0.00036	CcSEcCtD
Ziprasidone—Feeling abnormal—Capecitabine—stomach cancer	9.13e-05	0.000359	CcSEcCtD
Ziprasidone—Angiopathy—Doxorubicin—stomach cancer	9.12e-05	0.000359	CcSEcCtD
Ziprasidone—Muscle spasms—Epirubicin—stomach cancer	9.09e-05	0.000358	CcSEcCtD
Ziprasidone—Immune system disorder—Doxorubicin—stomach cancer	9.08e-05	0.000357	CcSEcCtD
Ziprasidone—Vertigo—Methotrexate—stomach cancer	9.08e-05	0.000357	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Capecitabine—stomach cancer	9.06e-05	0.000356	CcSEcCtD
Ziprasidone—Mediastinal disorder—Doxorubicin—stomach cancer	9.06e-05	0.000356	CcSEcCtD
Ziprasidone—Abdominal pain—Docetaxel—stomach cancer	9.04e-05	0.000356	CcSEcCtD
Ziprasidone—Body temperature increased—Docetaxel—stomach cancer	9.04e-05	0.000356	CcSEcCtD
Ziprasidone—Leukopenia—Methotrexate—stomach cancer	9.04e-05	0.000356	CcSEcCtD
Ziprasidone—Chills—Doxorubicin—stomach cancer	9.02e-05	0.000355	CcSEcCtD
Ziprasidone—Arrhythmia—Doxorubicin—stomach cancer	8.98e-05	0.000353	CcSEcCtD
Ziprasidone—Vision blurred—Epirubicin—stomach cancer	8.91e-05	0.000351	CcSEcCtD
Ziprasidone—Alopecia—Doxorubicin—stomach cancer	8.88e-05	0.000349	CcSEcCtD
Ziprasidone—Cough—Methotrexate—stomach cancer	8.82e-05	0.000347	CcSEcCtD
Ziprasidone—Mental disorder—Doxorubicin—stomach cancer	8.8e-05	0.000346	CcSEcCtD
Ziprasidone—Urticaria—Capecitabine—stomach cancer	8.8e-05	0.000346	CcSEcCtD
Ziprasidone—Abdominal pain—Capecitabine—stomach cancer	8.76e-05	0.000345	CcSEcCtD
Ziprasidone—Body temperature increased—Capecitabine—stomach cancer	8.76e-05	0.000345	CcSEcCtD
Ziprasidone—Malnutrition—Doxorubicin—stomach cancer	8.75e-05	0.000344	CcSEcCtD
Ziprasidone—Erythema—Doxorubicin—stomach cancer	8.75e-05	0.000344	CcSEcCtD
Ziprasidone—Anaemia—Epirubicin—stomach cancer	8.74e-05	0.000344	CcSEcCtD
Ziprasidone—Agitation—Epirubicin—stomach cancer	8.69e-05	0.000342	CcSEcCtD
Ziprasidone—Flatulence—Doxorubicin—stomach cancer	8.62e-05	0.000339	CcSEcCtD
Ziprasidone—Chest pain—Methotrexate—stomach cancer	8.6e-05	0.000338	CcSEcCtD
Ziprasidone—Myalgia—Methotrexate—stomach cancer	8.6e-05	0.000338	CcSEcCtD
Ziprasidone—Arthralgia—Methotrexate—stomach cancer	8.6e-05	0.000338	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	8.54e-05	0.000336	CcSEcCtD
Ziprasidone—Vertigo—Epirubicin—stomach cancer	8.49e-05	0.000334	CcSEcCtD
Ziprasidone—Syncope—Epirubicin—stomach cancer	8.48e-05	0.000334	CcSEcCtD
Ziprasidone—Leukopenia—Epirubicin—stomach cancer	8.46e-05	0.000333	CcSEcCtD
Ziprasidone—Back pain—Doxorubicin—stomach cancer	8.46e-05	0.000333	CcSEcCtD
Ziprasidone—Hypersensitivity—Docetaxel—stomach cancer	8.43e-05	0.000332	CcSEcCtD
Ziprasidone—Muscle spasms—Doxorubicin—stomach cancer	8.41e-05	0.000331	CcSEcCtD
Ziprasidone—Palpitations—Epirubicin—stomach cancer	8.35e-05	0.000329	CcSEcCtD
Ziprasidone—Confusional state—Methotrexate—stomach cancer	8.31e-05	0.000327	CcSEcCtD
Ziprasidone—Loss of consciousness—Epirubicin—stomach cancer	8.31e-05	0.000327	CcSEcCtD
Ziprasidone—Cough—Epirubicin—stomach cancer	8.25e-05	0.000325	CcSEcCtD
Ziprasidone—Vision blurred—Doxorubicin—stomach cancer	8.24e-05	0.000324	CcSEcCtD
Ziprasidone—Asthenia—Docetaxel—stomach cancer	8.21e-05	0.000323	CcSEcCtD
Ziprasidone—Infection—Methotrexate—stomach cancer	8.19e-05	0.000322	CcSEcCtD
Ziprasidone—Hypertension—Epirubicin—stomach cancer	8.16e-05	0.000321	CcSEcCtD
Ziprasidone—Hypersensitivity—Capecitabine—stomach cancer	8.16e-05	0.000321	CcSEcCtD
Ziprasidone—Nervous system disorder—Methotrexate—stomach cancer	8.09e-05	0.000318	CcSEcCtD
Ziprasidone—Anaemia—Doxorubicin—stomach cancer	8.08e-05	0.000318	CcSEcCtD
Ziprasidone—Thrombocytopenia—Methotrexate—stomach cancer	8.07e-05	0.000318	CcSEcCtD
Ziprasidone—Myalgia—Epirubicin—stomach cancer	8.05e-05	0.000317	CcSEcCtD
Ziprasidone—Arthralgia—Epirubicin—stomach cancer	8.05e-05	0.000317	CcSEcCtD
Ziprasidone—Chest pain—Epirubicin—stomach cancer	8.05e-05	0.000317	CcSEcCtD
Ziprasidone—Agitation—Doxorubicin—stomach cancer	8.04e-05	0.000316	CcSEcCtD
Ziprasidone—Anxiety—Epirubicin—stomach cancer	8.02e-05	0.000316	CcSEcCtD
Ziprasidone—Skin disorder—Methotrexate—stomach cancer	8.01e-05	0.000315	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	7.99e-05	0.000315	CcSEcCtD
Ziprasidone—Hyperhidrosis—Methotrexate—stomach cancer	7.97e-05	0.000314	CcSEcCtD
Ziprasidone—Asthenia—Capecitabine—stomach cancer	7.95e-05	0.000313	CcSEcCtD
Ziprasidone—Dry mouth—Epirubicin—stomach cancer	7.87e-05	0.00031	CcSEcCtD
Ziprasidone—Vertigo—Doxorubicin—stomach cancer	7.86e-05	0.000309	CcSEcCtD
Ziprasidone—Anorexia—Methotrexate—stomach cancer	7.86e-05	0.000309	CcSEcCtD
Ziprasidone—Syncope—Doxorubicin—stomach cancer	7.84e-05	0.000309	CcSEcCtD
Ziprasidone—Leukopenia—Doxorubicin—stomach cancer	7.83e-05	0.000308	CcSEcCtD
Ziprasidone—Diarrhoea—Docetaxel—stomach cancer	7.83e-05	0.000308	CcSEcCtD
Ziprasidone—Confusional state—Epirubicin—stomach cancer	7.78e-05	0.000306	CcSEcCtD
Ziprasidone—Palpitations—Doxorubicin—stomach cancer	7.73e-05	0.000304	CcSEcCtD
Ziprasidone—Hypotension—Methotrexate—stomach cancer	7.7e-05	0.000303	CcSEcCtD
Ziprasidone—Loss of consciousness—Doxorubicin—stomach cancer	7.69e-05	0.000303	CcSEcCtD
Ziprasidone—Infection—Epirubicin—stomach cancer	7.67e-05	0.000302	CcSEcCtD
Ziprasidone—Cough—Doxorubicin—stomach cancer	7.63e-05	0.0003	CcSEcCtD
Ziprasidone—Shock—Epirubicin—stomach cancer	7.59e-05	0.000299	CcSEcCtD
Ziprasidone—Diarrhoea—Capecitabine—stomach cancer	7.58e-05	0.000298	CcSEcCtD
Ziprasidone—Nervous system disorder—Epirubicin—stomach cancer	7.57e-05	0.000298	CcSEcCtD
Ziprasidone—Dizziness—Docetaxel—stomach cancer	7.56e-05	0.000298	CcSEcCtD
Ziprasidone—Thrombocytopenia—Epirubicin—stomach cancer	7.55e-05	0.000297	CcSEcCtD
Ziprasidone—Hypertension—Doxorubicin—stomach cancer	7.55e-05	0.000297	CcSEcCtD
Ziprasidone—Tachycardia—Epirubicin—stomach cancer	7.53e-05	0.000296	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Methotrexate—stomach cancer	7.51e-05	0.000296	CcSEcCtD
Ziprasidone—Skin disorder—Epirubicin—stomach cancer	7.49e-05	0.000295	CcSEcCtD
Ziprasidone—Hyperhidrosis—Epirubicin—stomach cancer	7.46e-05	0.000294	CcSEcCtD
Ziprasidone—Insomnia—Methotrexate—stomach cancer	7.46e-05	0.000293	CcSEcCtD
Ziprasidone—Arthralgia—Doxorubicin—stomach cancer	7.45e-05	0.000293	CcSEcCtD
Ziprasidone—Myalgia—Doxorubicin—stomach cancer	7.45e-05	0.000293	CcSEcCtD
Ziprasidone—Chest pain—Doxorubicin—stomach cancer	7.45e-05	0.000293	CcSEcCtD
Ziprasidone—Anxiety—Doxorubicin—stomach cancer	7.42e-05	0.000292	CcSEcCtD
Ziprasidone—Paraesthesia—Methotrexate—stomach cancer	7.4e-05	0.000291	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	7.4e-05	0.000291	CcSEcCtD
Ziprasidone—Anorexia—Epirubicin—stomach cancer	7.35e-05	0.000289	CcSEcCtD
Ziprasidone—Dyspnoea—Methotrexate—stomach cancer	7.35e-05	0.000289	CcSEcCtD
Ziprasidone—Somnolence—Methotrexate—stomach cancer	7.33e-05	0.000288	CcSEcCtD
Ziprasidone—Dizziness—Capecitabine—stomach cancer	7.32e-05	0.000288	CcSEcCtD
Ziprasidone—Dry mouth—Doxorubicin—stomach cancer	7.28e-05	0.000287	CcSEcCtD
Ziprasidone—Vomiting—Docetaxel—stomach cancer	7.27e-05	0.000286	CcSEcCtD
Ziprasidone—Dyspepsia—Methotrexate—stomach cancer	7.26e-05	0.000286	CcSEcCtD
Ziprasidone—Rash—Docetaxel—stomach cancer	7.21e-05	0.000284	CcSEcCtD
Ziprasidone—Hypotension—Epirubicin—stomach cancer	7.21e-05	0.000284	CcSEcCtD
Ziprasidone—Dermatitis—Docetaxel—stomach cancer	7.21e-05	0.000284	CcSEcCtD
Ziprasidone—Confusional state—Doxorubicin—stomach cancer	7.2e-05	0.000283	CcSEcCtD
Ziprasidone—Decreased appetite—Methotrexate—stomach cancer	7.17e-05	0.000282	CcSEcCtD
Ziprasidone—Headache—Docetaxel—stomach cancer	7.17e-05	0.000282	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Methotrexate—stomach cancer	7.12e-05	0.00028	CcSEcCtD
Ziprasidone—Fatigue—Methotrexate—stomach cancer	7.11e-05	0.00028	CcSEcCtD
Ziprasidone—Infection—Doxorubicin—stomach cancer	7.09e-05	0.000279	CcSEcCtD
Ziprasidone—Vomiting—Capecitabine—stomach cancer	7.04e-05	0.000277	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Epirubicin—stomach cancer	7.03e-05	0.000277	CcSEcCtD
Ziprasidone—Shock—Doxorubicin—stomach cancer	7.02e-05	0.000276	CcSEcCtD
Ziprasidone—Nervous system disorder—Doxorubicin—stomach cancer	7e-05	0.000276	CcSEcCtD
Ziprasidone—Thrombocytopenia—Doxorubicin—stomach cancer	6.99e-05	0.000275	CcSEcCtD
Ziprasidone—Rash—Capecitabine—stomach cancer	6.98e-05	0.000275	CcSEcCtD
Ziprasidone—Insomnia—Epirubicin—stomach cancer	6.98e-05	0.000275	CcSEcCtD
Ziprasidone—Dermatitis—Capecitabine—stomach cancer	6.98e-05	0.000275	CcSEcCtD
Ziprasidone—Tachycardia—Doxorubicin—stomach cancer	6.97e-05	0.000274	CcSEcCtD
Ziprasidone—Headache—Capecitabine—stomach cancer	6.94e-05	0.000273	CcSEcCtD
Ziprasidone—Skin disorder—Doxorubicin—stomach cancer	6.93e-05	0.000273	CcSEcCtD
Ziprasidone—Paraesthesia—Epirubicin—stomach cancer	6.93e-05	0.000273	CcSEcCtD
Ziprasidone—Hyperhidrosis—Doxorubicin—stomach cancer	6.9e-05	0.000272	CcSEcCtD
Ziprasidone—Dyspnoea—Epirubicin—stomach cancer	6.88e-05	0.000271	CcSEcCtD
Ziprasidone—Somnolence—Epirubicin—stomach cancer	6.86e-05	0.00027	CcSEcCtD
Ziprasidone—Anorexia—Doxorubicin—stomach cancer	6.81e-05	0.000268	CcSEcCtD
Ziprasidone—Nausea—Docetaxel—stomach cancer	6.79e-05	0.000267	CcSEcCtD
Ziprasidone—Feeling abnormal—Methotrexate—stomach cancer	6.79e-05	0.000267	CcSEcCtD
Ziprasidone—Dyspepsia—Epirubicin—stomach cancer	6.79e-05	0.000267	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Methotrexate—stomach cancer	6.74e-05	0.000265	CcSEcCtD
Ziprasidone—Decreased appetite—Epirubicin—stomach cancer	6.71e-05	0.000264	CcSEcCtD
Ziprasidone—Hypotension—Doxorubicin—stomach cancer	6.67e-05	0.000263	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Epirubicin—stomach cancer	6.66e-05	0.000262	CcSEcCtD
Ziprasidone—Fatigue—Epirubicin—stomach cancer	6.65e-05	0.000262	CcSEcCtD
Ziprasidone—Constipation—Epirubicin—stomach cancer	6.6e-05	0.00026	CcSEcCtD
Ziprasidone—Nausea—Capecitabine—stomach cancer	6.58e-05	0.000259	CcSEcCtD
Ziprasidone—Urticaria—Methotrexate—stomach cancer	6.55e-05	0.000258	CcSEcCtD
Ziprasidone—Body temperature increased—Methotrexate—stomach cancer	6.52e-05	0.000256	CcSEcCtD
Ziprasidone—Abdominal pain—Methotrexate—stomach cancer	6.52e-05	0.000256	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Doxorubicin—stomach cancer	6.5e-05	0.000256	CcSEcCtD
Ziprasidone—Insomnia—Doxorubicin—stomach cancer	6.46e-05	0.000254	CcSEcCtD
Ziprasidone—Paraesthesia—Doxorubicin—stomach cancer	6.41e-05	0.000252	CcSEcCtD
Ziprasidone—Dyspnoea—Doxorubicin—stomach cancer	6.36e-05	0.00025	CcSEcCtD
Ziprasidone—Feeling abnormal—Epirubicin—stomach cancer	6.36e-05	0.00025	CcSEcCtD
Ziprasidone—Somnolence—Doxorubicin—stomach cancer	6.35e-05	0.00025	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Epirubicin—stomach cancer	6.31e-05	0.000248	CcSEcCtD
Ziprasidone—Dyspepsia—Doxorubicin—stomach cancer	6.28e-05	0.000247	CcSEcCtD
Ziprasidone—Decreased appetite—Doxorubicin—stomach cancer	6.21e-05	0.000244	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Doxorubicin—stomach cancer	6.16e-05	0.000243	CcSEcCtD
Ziprasidone—Fatigue—Doxorubicin—stomach cancer	6.15e-05	0.000242	CcSEcCtD
Ziprasidone—Urticaria—Epirubicin—stomach cancer	6.13e-05	0.000241	CcSEcCtD
Ziprasidone—Constipation—Doxorubicin—stomach cancer	6.1e-05	0.00024	CcSEcCtD
Ziprasidone—Body temperature increased—Epirubicin—stomach cancer	6.1e-05	0.00024	CcSEcCtD
Ziprasidone—Abdominal pain—Epirubicin—stomach cancer	6.1e-05	0.00024	CcSEcCtD
Ziprasidone—Hypersensitivity—Methotrexate—stomach cancer	6.07e-05	0.000239	CcSEcCtD
Ziprasidone—Asthenia—Methotrexate—stomach cancer	5.92e-05	0.000233	CcSEcCtD
Ziprasidone—Feeling abnormal—Doxorubicin—stomach cancer	5.88e-05	0.000232	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Doxorubicin—stomach cancer	5.84e-05	0.00023	CcSEcCtD
Ziprasidone—Hypersensitivity—Epirubicin—stomach cancer	5.68e-05	0.000224	CcSEcCtD
Ziprasidone—Urticaria—Doxorubicin—stomach cancer	5.67e-05	0.000223	CcSEcCtD
Ziprasidone—Body temperature increased—Doxorubicin—stomach cancer	5.64e-05	0.000222	CcSEcCtD
Ziprasidone—Abdominal pain—Doxorubicin—stomach cancer	5.64e-05	0.000222	CcSEcCtD
Ziprasidone—Diarrhoea—Methotrexate—stomach cancer	5.64e-05	0.000222	CcSEcCtD
Ziprasidone—Asthenia—Epirubicin—stomach cancer	5.54e-05	0.000218	CcSEcCtD
Ziprasidone—Dizziness—Methotrexate—stomach cancer	5.45e-05	0.000215	CcSEcCtD
Ziprasidone—Diarrhoea—Epirubicin—stomach cancer	5.28e-05	0.000208	CcSEcCtD
Ziprasidone—Hypersensitivity—Doxorubicin—stomach cancer	5.26e-05	0.000207	CcSEcCtD
Ziprasidone—Vomiting—Methotrexate—stomach cancer	5.24e-05	0.000206	CcSEcCtD
Ziprasidone—Rash—Methotrexate—stomach cancer	5.2e-05	0.000205	CcSEcCtD
Ziprasidone—Dermatitis—Methotrexate—stomach cancer	5.19e-05	0.000204	CcSEcCtD
Ziprasidone—Headache—Methotrexate—stomach cancer	5.16e-05	0.000203	CcSEcCtD
Ziprasidone—Asthenia—Doxorubicin—stomach cancer	5.12e-05	0.000202	CcSEcCtD
Ziprasidone—Dizziness—Epirubicin—stomach cancer	5.1e-05	0.000201	CcSEcCtD
Ziprasidone—Vomiting—Epirubicin—stomach cancer	4.91e-05	0.000193	CcSEcCtD
Ziprasidone—Nausea—Methotrexate—stomach cancer	4.9e-05	0.000193	CcSEcCtD
Ziprasidone—Diarrhoea—Doxorubicin—stomach cancer	4.88e-05	0.000192	CcSEcCtD
Ziprasidone—Rash—Epirubicin—stomach cancer	4.86e-05	0.000191	CcSEcCtD
Ziprasidone—Dermatitis—Epirubicin—stomach cancer	4.86e-05	0.000191	CcSEcCtD
Ziprasidone—Headache—Epirubicin—stomach cancer	4.83e-05	0.00019	CcSEcCtD
Ziprasidone—Dizziness—Doxorubicin—stomach cancer	4.72e-05	0.000186	CcSEcCtD
Ziprasidone—Nausea—Epirubicin—stomach cancer	4.58e-05	0.00018	CcSEcCtD
Ziprasidone—Vomiting—Doxorubicin—stomach cancer	4.54e-05	0.000179	CcSEcCtD
Ziprasidone—Rash—Doxorubicin—stomach cancer	4.5e-05	0.000177	CcSEcCtD
Ziprasidone—Dermatitis—Doxorubicin—stomach cancer	4.5e-05	0.000177	CcSEcCtD
Ziprasidone—Headache—Doxorubicin—stomach cancer	4.47e-05	0.000176	CcSEcCtD
Ziprasidone—Nausea—Doxorubicin—stomach cancer	4.24e-05	0.000167	CcSEcCtD
Ziprasidone—CHRM1—Signaling by GPCR—IL6—stomach cancer	2.81e-06	1.58e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—JUN—stomach cancer	2.8e-06	1.58e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—IL6—stomach cancer	2.8e-06	1.57e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PPP2R1A—stomach cancer	2.79e-06	1.57e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—VEGFA—stomach cancer	2.79e-06	1.57e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—PIK3CA—stomach cancer	2.78e-06	1.56e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—VEGFA—stomach cancer	2.77e-06	1.56e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—IL6—stomach cancer	2.77e-06	1.56e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—TP53—stomach cancer	2.77e-06	1.56e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CCND1—stomach cancer	2.76e-06	1.56e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—IL6—stomach cancer	2.76e-06	1.55e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—STAT3—stomach cancer	2.76e-06	1.55e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—JUN—stomach cancer	2.76e-06	1.55e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CCND1—stomach cancer	2.76e-06	1.55e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—KRAS—stomach cancer	2.76e-06	1.55e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PPARG—stomach cancer	2.76e-06	1.55e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—JUN—stomach cancer	2.75e-06	1.55e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CCND1—stomach cancer	2.75e-06	1.55e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—STAT3—stomach cancer	2.75e-06	1.55e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—JUN—stomach cancer	2.74e-06	1.54e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CCND1—stomach cancer	2.74e-06	1.54e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GSTP1—stomach cancer	2.74e-06	1.54e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—JUN—stomach cancer	2.73e-06	1.54e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—MAPK3—stomach cancer	2.73e-06	1.54e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—MMP9—stomach cancer	2.73e-06	1.53e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—HRAS—stomach cancer	2.72e-06	1.53e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—TP53—stomach cancer	2.72e-06	1.53e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—KRAS—stomach cancer	2.72e-06	1.53e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—HRAS—stomach cancer	2.72e-06	1.53e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CDKN1A—stomach cancer	2.72e-06	1.53e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CCND1—stomach cancer	2.71e-06	1.53e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—JUN—stomach cancer	2.71e-06	1.52e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CCND1—stomach cancer	2.71e-06	1.52e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—HRAS—stomach cancer	2.7e-06	1.52e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—JUN—stomach cancer	2.7e-06	1.52e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—HMOX1—stomach cancer	2.7e-06	1.52e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CXCL8—stomach cancer	2.7e-06	1.52e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—VEGFA—stomach cancer	2.7e-06	1.52e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—TP53—stomach cancer	2.69e-06	1.51e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—MMP9—stomach cancer	2.68e-06	1.51e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—HRAS—stomach cancer	2.68e-06	1.51e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—MMP9—stomach cancer	2.68e-06	1.51e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CDKN1A—stomach cancer	2.67e-06	1.5e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—STAT3—stomach cancer	2.67e-06	1.5e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—MMP9—stomach cancer	2.67e-06	1.5e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CDKN1A—stomach cancer	2.67e-06	1.5e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—MMP9—stomach cancer	2.66e-06	1.5e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CDKN1A—stomach cancer	2.66e-06	1.5e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—PIK3CA—stomach cancer	2.66e-06	1.5e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—MYC—stomach cancer	2.66e-06	1.5e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—CAV1—stomach cancer	2.66e-06	1.49e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—VEGFA—stomach cancer	2.66e-06	1.49e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—MAPK8—stomach cancer	2.65e-06	1.49e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CDKN1A—stomach cancer	2.65e-06	1.49e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—APOA1—stomach cancer	2.65e-06	1.49e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—HRAS—stomach cancer	2.65e-06	1.49e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—MAPK3—stomach cancer	2.64e-06	1.48e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CDKN1B—stomach cancer	2.64e-06	1.48e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—MMP9—stomach cancer	2.63e-06	1.48e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—STAT3—stomach cancer	2.63e-06	1.48e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—MMP9—stomach cancer	2.63e-06	1.48e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CDKN1A—stomach cancer	2.62e-06	1.48e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—MAPK3—stomach cancer	2.62e-06	1.48e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CDKN1A—stomach cancer	2.62e-06	1.47e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—MAPK8—stomach cancer	2.61e-06	1.47e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—IL6—stomach cancer	2.61e-06	1.47e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—MAPK8—stomach cancer	2.6e-06	1.47e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—HRAS—stomach cancer	2.6e-06	1.46e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—IL6—stomach cancer	2.6e-06	1.46e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—MAPK1—stomach cancer	2.6e-06	1.46e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—EGFR—stomach cancer	2.6e-06	1.46e-05	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—PIK3CA—stomach cancer	2.6e-06	1.46e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—MAPK8—stomach cancer	2.6e-06	1.46e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—MAPK8—stomach cancer	2.59e-06	1.46e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—IL6—stomach cancer	2.59e-06	1.46e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—TP53—stomach cancer	2.57e-06	1.45e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—HRAS—stomach cancer	2.57e-06	1.45e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—IL6—stomach cancer	2.57e-06	1.44e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—MYC—stomach cancer	2.57e-06	1.44e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—MAPK8—stomach cancer	2.56e-06	1.44e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—MAPK8—stomach cancer	2.55e-06	1.44e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—MAPK3—stomach cancer	2.55e-06	1.44e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—MYC—stomach cancer	2.55e-06	1.44e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—TYMS—stomach cancer	2.54e-06	1.43e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.54e-06	1.43e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—PIK3CA—stomach cancer	2.53e-06	1.43e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—IL6—stomach cancer	2.53e-06	1.42e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—PIK3CA—stomach cancer	2.52e-06	1.42e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GSTM1—stomach cancer	2.51e-06	1.42e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CCND1—stomach cancer	2.51e-06	1.41e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—MAPK3—stomach cancer	2.51e-06	1.41e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—MAPK1—stomach cancer	2.51e-06	1.41e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—EGFR—stomach cancer	2.51e-06	1.41e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—JUN—stomach cancer	2.51e-06	1.41e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—PIK3CA—stomach cancer	2.5e-06	1.41e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—MAPK1—stomach cancer	2.5e-06	1.41e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—EGFR—stomach cancer	2.5e-06	1.4e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—IL6—stomach cancer	2.49e-06	1.4e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—MYC—stomach cancer	2.48e-06	1.4e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—ALB—stomach cancer	2.48e-06	1.39e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—HRAS—stomach cancer	2.46e-06	1.38e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—IL6—stomach cancer	2.46e-06	1.38e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—KRAS—stomach cancer	2.46e-06	1.38e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—TP53—stomach cancer	2.45e-06	1.38e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—VEGFA—stomach cancer	2.45e-06	1.38e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—MYC—stomach cancer	2.44e-06	1.38e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—MMP9—stomach cancer	2.44e-06	1.37e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CDKN1A—stomach cancer	2.43e-06	1.37e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—MAPK1—stomach cancer	2.43e-06	1.37e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—EGFR—stomach cancer	2.43e-06	1.37e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—STAT3—stomach cancer	2.42e-06	1.36e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—TP53—stomach cancer	2.42e-06	1.36e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—VEGFA—stomach cancer	2.41e-06	1.36e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—VEGFA—stomach cancer	2.4e-06	1.35e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—VEGFA—stomach cancer	2.4e-06	1.35e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—MAPK1—stomach cancer	2.39e-06	1.35e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—EGFR—stomach cancer	2.39e-06	1.34e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—VEGFA—stomach cancer	2.39e-06	1.34e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—STAT3—stomach cancer	2.39e-06	1.34e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—STAT3—stomach cancer	2.38e-06	1.34e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—MAPK8—stomach cancer	2.37e-06	1.34e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—STAT3—stomach cancer	2.37e-06	1.34e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—NOS3—stomach cancer	2.37e-06	1.33e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—KRAS—stomach cancer	2.37e-06	1.33e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—VEGFA—stomach cancer	2.37e-06	1.33e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—STAT3—stomach cancer	2.37e-06	1.33e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—ERCC2—stomach cancer	2.36e-06	1.33e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—VEGFA—stomach cancer	2.36e-06	1.33e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—KRAS—stomach cancer	2.36e-06	1.33e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—IL6—stomach cancer	2.35e-06	1.32e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—HRAS—stomach cancer	2.34e-06	1.32e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—STAT3—stomach cancer	2.34e-06	1.32e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—STAT3—stomach cancer	2.34e-06	1.31e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PPARG—stomach cancer	2.34e-06	1.31e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—MAPK3—stomach cancer	2.32e-06	1.3e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—HRAS—stomach cancer	2.31e-06	1.3e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—KRAS—stomach cancer	2.29e-06	1.29e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—MAPK3—stomach cancer	2.28e-06	1.28e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—MAPK3—stomach cancer	2.27e-06	1.28e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—MAPK3—stomach cancer	2.27e-06	1.28e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—MAPK3—stomach cancer	2.26e-06	1.27e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—KRAS—stomach cancer	2.26e-06	1.27e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—PIK3CA—stomach cancer	2.26e-06	1.27e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—MYC—stomach cancer	2.25e-06	1.27e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—IL6—stomach cancer	2.24e-06	1.26e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—MAPK3—stomach cancer	2.24e-06	1.26e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—MAPK3—stomach cancer	2.23e-06	1.26e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—PIK3CA—stomach cancer	2.23e-06	1.26e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—MTHFR—stomach cancer	2.22e-06	1.25e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—MYC—stomach cancer	2.22e-06	1.25e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—IL6—stomach cancer	2.21e-06	1.25e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—MYC—stomach cancer	2.21e-06	1.24e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—MYC—stomach cancer	2.2e-06	1.24e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—MAPK1—stomach cancer	2.2e-06	1.24e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—EGFR—stomach cancer	2.2e-06	1.24e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—MYC—stomach cancer	2.2e-06	1.24e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—VEGFA—stomach cancer	2.19e-06	1.23e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—TP53—stomach cancer	2.18e-06	1.23e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—PIK3CA—stomach cancer	2.18e-06	1.23e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—MYC—stomach cancer	2.18e-06	1.22e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—MYC—stomach cancer	2.17e-06	1.22e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—STAT3—stomach cancer	2.17e-06	1.22e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—MAPK1—stomach cancer	2.17e-06	1.22e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PTGS2—stomach cancer	2.17e-06	1.22e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—EGFR—stomach cancer	2.17e-06	1.22e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—PIK3CA—stomach cancer	2.17e-06	1.22e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—MAPK1—stomach cancer	2.16e-06	1.22e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—EGFR—stomach cancer	2.16e-06	1.22e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—MAPK1—stomach cancer	2.16e-06	1.21e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—EGFR—stomach cancer	2.16e-06	1.21e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—MAPK1—stomach cancer	2.15e-06	1.21e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—EGFR—stomach cancer	2.15e-06	1.21e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—MAPK1—stomach cancer	2.13e-06	1.2e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—EGFR—stomach cancer	2.13e-06	1.2e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—MAPK1—stomach cancer	2.12e-06	1.19e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—EGFR—stomach cancer	2.12e-06	1.19e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—PIK3CA—stomach cancer	2.11e-06	1.19e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—TP53—stomach cancer	2.11e-06	1.19e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—ALB—stomach cancer	2.1e-06	1.18e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—TP53—stomach cancer	2.1e-06	1.18e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—HRAS—stomach cancer	2.09e-06	1.17e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—KRAS—stomach cancer	2.08e-06	1.17e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—PIK3CA—stomach cancer	2.07e-06	1.17e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—MAPK3—stomach cancer	2.07e-06	1.17e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—CAV1—stomach cancer	2.05e-06	1.15e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—KRAS—stomach cancer	2.05e-06	1.15e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—PIK3CA—stomach cancer	2.05e-06	1.15e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—APOA1—stomach cancer	2.05e-06	1.15e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—KRAS—stomach cancer	2.04e-06	1.15e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—TP53—stomach cancer	2.04e-06	1.15e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—KRAS—stomach cancer	2.04e-06	1.15e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—KRAS—stomach cancer	2.03e-06	1.14e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—MYC—stomach cancer	2.02e-06	1.13e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—HRAS—stomach cancer	2.02e-06	1.13e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—KRAS—stomach cancer	2.01e-06	1.13e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—NOS3—stomach cancer	2.01e-06	1.13e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—TP53—stomach cancer	2.01e-06	1.13e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—KRAS—stomach cancer	2.01e-06	1.13e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—HRAS—stomach cancer	2e-06	1.13e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—IL6—stomach cancer	2e-06	1.12e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—MAPK1—stomach cancer	1.97e-06	1.11e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—EGFR—stomach cancer	1.97e-06	1.11e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—HRAS—stomach cancer	1.95e-06	1.1e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—IL6—stomach cancer	1.93e-06	1.09e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—HRAS—stomach cancer	1.92e-06	1.08e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—IL6—stomach cancer	1.92e-06	1.08e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—PIK3CA—stomach cancer	1.91e-06	1.08e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—PIK3CA—stomach cancer	1.88e-06	1.06e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—PIK3CA—stomach cancer	1.88e-06	1.06e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—PIK3CA—stomach cancer	1.88e-06	1.06e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—PIK3CA—stomach cancer	1.87e-06	1.05e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—IL6—stomach cancer	1.87e-06	1.05e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—PIK3CA—stomach cancer	1.87e-06	1.05e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—KRAS—stomach cancer	1.86e-06	1.05e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—TP53—stomach cancer	1.85e-06	1.04e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—PIK3CA—stomach cancer	1.85e-06	1.04e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—PIK3CA—stomach cancer	1.84e-06	1.04e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PTGS2—stomach cancer	1.84e-06	1.03e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—IL6—stomach cancer	1.84e-06	1.03e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—TP53—stomach cancer	1.82e-06	1.02e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—TP53—stomach cancer	1.82e-06	1.02e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—TP53—stomach cancer	1.81e-06	1.02e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—TP53—stomach cancer	1.8e-06	1.02e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PPARG—stomach cancer	1.8e-06	1.01e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—TP53—stomach cancer	1.79e-06	1.01e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—TP53—stomach cancer	1.78e-06	1e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—HRAS—stomach cancer	1.77e-06	9.96e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—HRAS—stomach cancer	1.74e-06	9.8e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—HRAS—stomach cancer	1.74e-06	9.78e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—HRAS—stomach cancer	1.73e-06	9.74e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—HRAS—stomach cancer	1.73e-06	9.71e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—PIK3CA—stomach cancer	1.71e-06	9.63e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—HRAS—stomach cancer	1.71e-06	9.62e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—HRAS—stomach cancer	1.7e-06	9.59e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—IL6—stomach cancer	1.69e-06	9.53e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—IL6—stomach cancer	1.67e-06	9.38e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—IL6—stomach cancer	1.66e-06	9.36e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—IL6—stomach cancer	1.66e-06	9.33e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—TP53—stomach cancer	1.66e-06	9.32e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—IL6—stomach cancer	1.65e-06	9.3e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—IL6—stomach cancer	1.64e-06	9.21e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—IL6—stomach cancer	1.63e-06	9.18e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—ALB—stomach cancer	1.62e-06	9.12e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—HRAS—stomach cancer	1.58e-06	8.91e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—NOS3—stomach cancer	1.55e-06	8.72e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IL6—stomach cancer	1.52e-06	8.53e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PTGS2—stomach cancer	1.42e-06	7.98e-06	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PIK3CA—stomach cancer	1.33e-06	7.51e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PIK3CA—stomach cancer	1.13e-06	6.36e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PIK3CA—stomach cancer	8.72e-07	4.91e-06	CbGpPWpGaD
